Detalla, Baby Girl .

HRN: 27-01-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2025
AMPICILLIN 250MG (VIAL)
04/27/2025
05/03/2025
IV
45 Mg
Q12H
Preterm Newborn
Waiting Final Action 
04/27/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/27/2025
05/03/2025
IV
10 Mg
Q36H
Preterm Newborn
Waiting Final Action 
04/28/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
04/28/2025
05/05/2025
IV
10mg As LD Then 5mg
Q48H
Candida Prophylaxis
Waiting Final Action 
04/29/2025
CEFOTAXIME 500MG (VIAL)
04/29/2025
05/06/2025
IV
45mg
Q12
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: